| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 4 |
| 1 | AZACITIDINE | 3 |
| 2 | AZACITIDINE FOR | 3 |
| 3 | ACYCLOVIR | 2 |
| 4 | BLINATUMOMAB | 2 |
| 5 | CYCLOPHOSPHAMIDE | 2 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 8 | FEBUXOSTAT | 2 |
| 9 | FEBUXOSTAT TABLETS 40 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 1 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 2 | CLOFARABINE | 1 | 0.0004 |
| 3 | RASBURICASE | 1 | 0.0004 |
| 4 | LETERMOVIR | 1 | 0.0003 |
| 5 | TREMELIMUMAB | 1 | 0.0002 |
| 6 | ALBUMIN HUMAN | 1 | 0.0002 |
| 7 | FEBUXOSTAT TABLETS 40 MG | 2 | 0.0002 |
| 8 | BLINATUMOMAB | 2 | 0.0002 |
| 9 | RAMUCIRUMAB | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 6 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 7 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 9 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |